NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $55,196 | -29.2% | 24,423 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $78,000 | -25.0% | 24,423 | -10.9% | 0.01% | -28.6% |
| Q2 2022 | $104,000 | +38.7% | 27,412 | +97.1% | 0.01% | +40.0% |
| Q1 2022 | $75,000 | -88.0% | 13,906 | -59.5% | 0.01% | -78.3% |
| Q3 2019 | $626,000 | -11.3% | 34,367 | +73.3% | 0.05% | -17.9% |
| Q2 2019 | $706,000 | +6.0% | 19,834 | 0.0% | 0.06% | -11.1% |
| Q1 2019 | $666,000 | -2.9% | 19,834 | -5.0% | 0.06% | +12.5% |
| Q4 2018 | $686,000 | +259.2% | 20,878 | +34.0% | 0.06% | +194.7% |
| Q1 2017 | $191,000 | 0.0% | 15,584 | 0.0% | 0.02% | -26.9% |
| Q4 2016 | $191,000 | – | 15,584 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |